2024 CPIP-D Case 4: Transfusion Medicine – Navigating Blood Bank Regulations for the General Practice Pathologist - CPIP0404W.2024
Untitled Document


This clinical pathology activity is intended for pathologists.

Credit Type: CME
Duration: 1 hour 15 minutes
Launch Date: April 15, 2024
Expiration Date: April 14, 2027, 11:59 PM (CT)
Pricing: Junior Member Fee: $10.00
MOC Category: Medical Knowledge, Patient Care

Registration Information
THIS ACTIVITY REQUIRES CREDIT CARD PAYMENT. If you ordered this product in advance, click Learning Search to locate the activity.

To enroll in the series with one easy payment, or to enroll multiple participants from the same institution, call 800-323-4040 option 1. This option is only available until December 31, 2024, after this date this activity is only accessible by an online credit card payment.

Description
Blood products are deemed both a biological and a drug by the Food and Drug Administration, being that they are derived from human donors and therefore subject to unique risks therein. Transfusion safety is paramount to patient care. Reporting of factors that could negatively impact the safety, purity, and potency of blood products, and adverse events related to transfusion is critical at the local, regional, and national levels. Monitoring such events improves future safety and allows for risks to be mitigated at a population level. Blood banks are subject to ample regulatory oversight, and the pursuit of additional accreditation provides credibility and enhances patient safety and quality.

This clinical pathology activity is intended for pathologists.

Objectives
After completing this activity, you should be able to:

  1. Differentiate between regulatory and accreditation requirements and describe elements of each.
  2. Define biological product deviation (BPD) and differentiate BPD events that are reportable to the Food and Drug Administration versus those that are not.
  3. Evaluate a possible transfusion-related death and describe the process for reporting it to the Food and Drug Administration.

Authors/Faculty
Melissa Robin George, DO, FCAP

Related Link
Clinical Pathology Improvement Program

CME Information
Accreditation: The College of American Pathologists (CAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Category 1: The College of American Pathologists designates this internet enduring material educational activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Payment Information
To pay with a check, print a copy of this page and send it with your check to the address below. You will be notified when your payment has been processed and you have been registered into the activity.

College of American Pathologists
CAP Learning
325 Waukegan Road
Northfield, IL 60093-2750

Refund Policy
Refunds will be handled on an exception basis. Please submit your request to the CAP in writing via email at education@cap.org or fax at 847-832-8006.

Technical Requirements
Pop-up blockers must be turned off.

The CAP recognizes that some Veteran’s Administration, US Government, and military participants may have difficulty accessing the online activity. If you experience difficulty or have any questions, please contact a representative of the Customer Contact Center at 800-323-4040 option 1 or education@cap.org.

Availability
This activity and evaluation are available April 15, 2024, and expire April 14, 2027, at 11:59 PM (CT). Upon completion of the activity your credit will be awarded. Your certificate may be downloaded from your Transcript.

CC: CPIP0404W.2024






Non-Member Price:   $65.00  
 
Member Price:  $50.00   


2024 CPIP-D Case 4: Transfusion Medicine – Navigating Blood Bank Regulations for the General Practice Pathologist